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Abstract
The apoptotic effect of bacteria-derived β-glucan was investigated in human colon cancer cells SNU-C4 using terminal deoxynucleotidyl transferase
(TdT)-mediated dUTP nick end labeling (TUNEL) assay, reverse transcription-polymerase chain reaction (RT-PCR) expressions of Bcl-2, Bax, and 
Caspase-3 genes, and assay of caspase-3 enzyme activity. β-Glucan of 10, 50, and 100 μg/mL decreased cell viability in a dose-dependent manner
with typical apoptotic characteristics, such as morphological changes of chromatin condensation and apoptotic body formation from TUNEL assay.
In addition, β-glucan (100 μg/mL) decreased the expression of Bcl-2 by 0.6 times, whereas the expression of Bax and Caspase-3 were increased 
by 3.1 and 2.3 times, respectively, compared to untreated control group. Furthermore, the caspase-3 activity in the β-glucan-treated group was significantly
increased compared to those in control group (P< 0.05). Bacterial derived β-glucan could be used as an effective compound inducing apoptosis
in human colon cancer.
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Introduction
Generally,  β-glucan, which has β-1,3 and 1,4 glycosides 
linkage of D-glucose, was derived from oats (Behall et al., 1997; 
Davidson et al, 1991), barley (McIntosh et al., 1991) or yeast 
(Nicolosi et al., 1999). β-Glucan have been reported to inhibit 
the growth of bacteria, virus, and fungus (Nameda et al., 2007), 
to stimulate macrophages as immune enhancer (Volman et al., 
2008), and to reduce cholesterol level (Newman et al., 1989) 
and glucose concentration (Hong et al., 2005) in the blood. 
Several mechanisms have been proposed for the protective and 
health beneficial effects of β-glucan including antioxidant 
capacity (Novak & Vetvicka, 2008; Ohno et al., 1996) and 
functional properties as dietary fiber source.
β-Glucan can be derived from Alcaligenes and Agrobacterium 
species and their β-glucan has a homopolymeric structure with 
linear β-1,3-glucosidic linkage (Hong et al., 2005). Physiological 
effects of bacteria-derived β-glucan including anti-cancer activity 
has not been reported in the literature. Enhancing apoptosis of 
cancer cells is one of representative methods for searching 
anti-cancer candidates.
Apoptosis, known as programmed cell death, is an essential 
physiologic process in the normal development for maintaining 
cell homeostasis. Therapeutic strategy for cancer is induction of 
apoptosis, and many cancers are underlined by the identification 
of many oncogenes as regulators of apoptosis such as Bcl-2. 
Bcl-2 was the first isolated protein that regulated the life or death 
of a cell through controlling the release of mitochondrial 
apoptogenic factors that are associated with death protease called 
caspases (Oltvai et al., 1993). For these reasons, apoptosis has 
been a very essential event for the researchers who seek new 
strategies against cancer. Although many studies on the 
anti-tumor effects of β-glucan have been reported, anti-colon 
cancer mechanism of β-glucan through caspase pathway has not 
fully understood. 
Therefore, the objective of this study was to examine apoptotic 
effects of bacteria-derived β-glucan on human colon cancer cells 
SNU-C4 through caspase-3 pathway.Mi-Ja Kim et al. 181
Materials and Methods
Materials
β-Glucan produced by fermentation with a mutant strain of 
Aureobasidum species was obtained from Korea Research 
Institute of Bioscience and Biotechnology (Jeongeup, Korea). 
The structure of β-glucan produced by Aureobasidum species 
was a homopolymer with β-1,3 glycosidic bond, which had high 
viscosity and solubility (Hong et al., 2005).
Cell culture
Human colon cancer SNU-C4 cells were obtained from Korean 
Cell Line Bank (KCLB, Seoul, Korea). Cells were maintained 
in RPMI 1640 medium (Gibco, Grand Island, NY, USA) 
supplemented with 10% heat-inactivated fetal bovine serum 
(FBS) (Gibco, Grand Island, NY, USA). Cells were grown in 
a humidified incubator at 37℃ i n  a n  a t m o s p h e r e  o f  5 %  C O 2 
and 95% air.
MTT assay
Cytotoxicity was performed by MTT assay (Sigma, St. Louis, 
MO, USA) as previously described (Park et al., 2008). In brief, 
SNU-C4 cells were cultured in each well of a 96-well plate 
(Coring Incorporated, Coring, NY, USA). The β-glucan was 
added to the cells with the concentrations of 1, 5, 10, 20, 25, 
50, 100, and 200 μg/mL at 24 hr. Control was the cells without 
addition of β-glucan. After a further 24 hrs incubation, 20 μL 
of MTT was added to each well and incubated for 4 hr. After 
the plate was incubated in the dark for 4 hr, the medium was 
discarded and 150 μL of DMSO was added to each well and 
incubated for 20 min. The absorbance at a test wavelength of 
540 nm with a reference wavelength of 690 nm was measured 
using a microtiter plate reader (Molecular Devices, CA, USA). 
The optical density (O.D.) was calculated as the difference 
between the absorbance from reference wavelength and from test 
wavelength. Percent viability was calculated as (O.D. of β-glucan 
treated sample / O.D. of none treated sample) ×100.
TUNEL assay
Cell samples were fixed using a freshly prepared solution (4% 
paraformaldehyde in PBS, pH 7.4) for 1 hr at 15-25℃  and 
incubated in permeabilization solution (0.1% Trixon X-100 in 
0.1% sodium citrate) for 2 min on ice. Then a 50 μL TUNEL 
(Roche) reaction mixture was added to samples and incubated 
for 60 min at 37℃ in a humidified atmosphere in the dark. After 
converted-POD (antibody conjugated with peroxidase) solution 
was added, the cells were incubated for 30 min. The DNA 
fragments stained using 3, 3′-diaminobenzidine (Sigma, St. 
Louis, MO, USA) were used as substrates for the peroxidase. 
RT-PCR of Bcl-2, Bax, and Caspase-3 
The procedures of RT-PCR were the same as in the previous 
study (Park et al., 2008). Briefly, total RNA of cells was extracted 
by Trizol (Invitrogen, Carlsbad, CA, USA). cDNA synthesis was 
performed in 20 μL reaction system of reverse transcription 
including 2 μg RNA. The expression of apoptosis-related genes, 
Bcl-2, Bax and Caspase-3, was determined by RT-PCR. PCR 
was performed with the following primers for Bcl-2 (5′-TCC 
GTG CCT GAC TTT AGC AAG CTG-3′ and 5′-GGA ATC 
CCA ACC AGA GAT CTC AA-3′), for Bax (5′-AGA TGA ACT 
GGA TAG CAA TAT GGA-3′ and 5′-CCA CCC TGG TCT 
TGG ATC CAG ACA-3′) and for Caspase-3 (5′-CTT GGT AGA 
TCG GCC ATC TGA AAC-3′ and 5′-GGT CCC GTA CAG 
GTG TGC TTC GAC-3′). The Cyclophilin (5′-ACC CCA CCG 
TGT TCT TCG AC-3′ and 5′-CAT TTG CCA TGG ACA AGA 
TG-3′) was used as an internal control. The annealing 
temperature was 50℃ for Bcl-2 and Bax, 57℃ for Caspase-3, 
and 56℃ for Cyclophilin. The amplified fragment sizes of Bcl-2, 
Bax, Caspase-3, and Cyclophilin were 333-bp, 260-bp, 405-bp 
and 300-bp, respectively. PCR products were separated by 2% 
agarose gel electrophoresis, then scanned and analyzed by image 
analyzer. 
Caspase-3 activity assay
Caspase-3 activity was measured with a caspase-3 assay kit 
(Sigma, St. Louis, MO, USA) according to the manufacturer’s 
protocol. SNU-C4  cells were lysed with lysis buffer after 
treatment with β-glucan (50 and 100 μg/mL) for 24 hr. Caspase-3 
was used as a positive control for comparison. All mixtures were 
incubated overnight in a humidified environment at 37℃. The 
concentration of the p-nitroanyline (p-NA) released from the 
substrate was measured at 405 nm. 
Statistical analysis
Data were expressed as Mean ± SEM and analyzed using 
ANOVA. Duncan’s post-hoc analyzed using SPSS program. A 
P < 0.05 was considered significant. 
Results 
Effect of β-glucan on the SNU-C4 cell viability 
Dosage effects of β-glucan on the viability of SNU-C4 cells 
are shown in Figure 1. β-Glucan treatment displayed a significant 
dose-dependent decrease in cell viability (P< 0.05). Viability of 
cells treated with β-glucan at the concentrations of 0, 1, 5, 10, 
20, 25, 50, 75, 100, 150, and 200 μg/mL for 24 hr was 100.0
± 1.7, 90.7 ± 0.6, 83.7 ± 2.5, 63.4 ± 3.6, 62.2 ± 1.1, 63.0 ± 3.3, 
60.6 ± 0.9, 59.7 ± 1.0, 57.2 ± 1.5, 52.6 ± 1.2, and 44.7 ± 1.6% of 
control, respectively (Fig. 1). This result indicates that β-glucan 182 Apoptotic effect of β-glucan in human colon cancer cells
Fig. 1. Cell viability of β-glucan in human colon cancer cells SNU-C4 for 24 
hrs. Viability was determined with MTT assay. Results are presented  as mean ±
SEM.  The  experiments  were  done  triplicate.  Different  letters  denote  significant 
differences  within  each  group  (P< 0.05). 
(A)
(B)
Fig. 2. Morphological change of β-glucan induced cell death in human colon 
cancer cells SNU-C4. Cells were cultured without resveratrol (A) or with 10, 50, 
and  100  μg/mL  of  β-glucan  ( B ,  C ,  a n d  D ) .  M o r p h o l o g y  ( t o p ) :  p h a s e - c o n t r a s t  
microscopy showed cell shrinkage, irregularity of shape in β-glucan treated cultures. 
TU NEL assay (bottom ): SNU-668 cells stained using TUNEL m ethod. Condensed 
and marginated chromatin showed to be stained dark brown. The experiments were 
done  triplicate.  Scale  bar,  100  μm.
(A)
    
(B)
Fig. 3. RT-PCR analysis of Bcl-2, Bax and Caspase-3. As the internal control, 
Cyclophilin mRNA was also β-glucan transcribed. A: control, B: 10 μg/mL of β
-glucan treated group, C: 50 μg/mL of β-glucan treated group, D: 100 μg/mL 
of β-glucan treated group. The experiments were done triplicate. Different letters 
denote  significant  differences  within  each  group  (P < 0.05). 
Fig. 4. Caspase-3 activity of β-glucan treated SNU-C4. The rate of DEVD-pNA 
cleavage  was  measured  at  405  nm.  Caspase-3  is  a  positive  control.  The 
experiments were done triplicate. Different letters means significantly different among 
groups  (P< 0.05). 
induced cell death in SNU-C4 cells with a dose-dependent 
manner. For further experiment, concentrations of 10, 50, and 
100  μg/mL  β-glucan were selected, which showed lower cell 
toxicity than 45%. Also, these concentrations have significantly 
higher cell toxicity than 0, 1, and 5 μg/mL and lower cell toxicity 
than 200 μg/mL.
Morphological changes of β-glucan on the SNU-C4
During the process of apoptosis in cells, DNA strand breaks 
occur and the nicks in DNA molecules can be quantitatively 
measured (Fig. 2A-B, C, and D). Through TUNEL in situ 
detection, we found that apoptotic cells were increased in 
SNU-C4 cells after 24 hr treatment with 10, 50, and 100 μg/mL 
(Fig. 2B-F, G, and H), compared to control without β-glucan 
treatment (Fig. 2B-E). The results of TUNEL assay can provide 
early phenomenon for apoptosis as the loss of mitochondrial 
membrane potential (Moudy et al., 1995; Smiley et al., 1991).
Expression of Bcl-2, Bax, and Caspase-3 genes on β-glcuan 
treated SNU-C4
RT-PCR analysis of the mRNA levels of Bcl-2, Bax, and 
Caspase-3 was performed to estimate the expression of 
apoptosis-related genes (Fig. 3A). The expression of Bcl-2 was 
decreased significantly by 0.5 and 0.6 times in β-glucan treated 
with 50 and 100 μg/mL respectively, compared to that of control 
(P < 0.05) (Fig. 3B). Also, the effect of β-glucan treatment on 
the expression of Bax gene was increased significantly by 1.7, 
2.5, and 3.1 times in β-glucan treated with 10, 50, and 100 μ
g/mL, respectively, compared to control (P < 0.05) (Fig. 3B). 
Finally, gene expression of Caspase-3 was increased significantly 
by 1.5, and 2.3 times in β-glucan treated with 50, and 100 μg/mL, 
respectively, compared to control (P<0 . 0 5 )  ( F i g .  3 B ) .  T h e  m o s t 
effective concentrations for the expression of these genes in 
SNU-C4 cells were 50 and 100 μg/mL of β-glucan.Mi-Ja Kim et al. 183
Caspase-3 activity on β-glucan treated SNU-C4
Caspase-3 enzyme activity in 50 and 100 μg/mL  β-glucan 
treated cells is shown in Fig. 4. The caspase-3 activities in 
SNU-C4 cells treated with 50 and 100 μg/mL were significantly 
higher than those of SNU-C4 cells without β-glucan (P < 0.05) 
while significantly lower than caspase-3 positive cells. However, 
caspase-3 activity of β-glucan treated cells between 50 and 100 
μg/mL was not significant.
Discussion 
The present study has demonstrated that β-glucan induced 
apoptosis in human colon cancer SNU-C4 cells. Addition of β
-glucan inhibited cell proliferation, induced apoptosis, led to 
changes of cell morphology and of the expression of apoptotic 
genes, and increased the activity of caspase-3 enzyme. Yamamoto 
et al. (2009) reported that β-glucan from mushroom induced 
suppression of angiogenesis and metastasis in orally administrated 
animal models. Kobayashi et al. (2005) demonstrated that the 
β-glucan from Agaricus blazei Murill reduced pulmonary 
metastasis of 3LL cells and peritoneal disseminated metastasis 
of HRA cells and inhibited the growth of these metastatic tumors 
in the lung. Previous studies reported that β-glucan has the ability 
of a potential anticancer agent in vitro and in vivo animal models. 
The results of this study suggested that β-glucan could induce 
apoptosis in human colon cancer cells. Furthermore, the results 
confirmed possible apoptosis inducing mechanisms of the β
-glucan through TUNEL assay, gene expressions related to 
apoptosis, and caspase-3 activity. Based on these results, β
-glucan induced apoptosis of human colon cancer cells at the 
concentration of 100 μg/mL. These cells undergoing apoptosis 
exhibit cytoplasmic blebbing, nuclear shrinkage, chromatin 
condensation, irregularity in shape and retraction (Cohen, 1993; 
Qiao et al., 1998). These characteristic changes were observed 
in the morphology of cells treated with 50 and 100 μg/mL  β
-glucan. RT-PCR analysis of the mRNA levels of Bcl-2 showed 
significantly decrease, and those of Bax and Caspase-3 were 
increased significantly with β-glucan treatment (P < 0.05). As 
many cancer cells exhibit abnormality induced by target 
compounds, exploiting these alterations of regulators induced by 
natural sources could be an efficient tool to screen promising 
therapeutic compounds for cancer treatment (Harlozinska, 2005; 
Siripong  et al., 2009). Numerous studies show that caspase-3 
pathway has anti-apoptotic effects which have been implicated 
in a variety of biological processes (Yang et al., 2009). The 
caspase-3 activity in the β-glucan treated group was significantly 
increased, compared to that in control group, implying that β
-glucan can induce apoptosis in cancer cells through caspase-3 
pathway.
In conclusion, the induction of apoptosis by β-glucan in colon 
cancer cells may be related with modulation of Bcl-2 family 
resulting in the activation of caspase-3 expression. It may be 
a beneficial natural agent for colon cancer treatment and 
chemoprevention.
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